肥胖对再次抗反流手术后胃食管反流病复发的影响
本研究回顾2012至2023年接受机器人再次抗反流手术的84例患者,按BMI分三组比较围手术期特征及术后GERD-HRQL评分。结果显示三组术后GERD-HRQL评分均较术前显著改善,且食管裂孔疝复发率与内镜复发率组间无差异,提示再次抗反流手术可能适用于不同BMI范围的患者。
要点
- 再次抗反流手术后,肥胖与非肥胖患者的GERD-HRQL评分均显著改善。
- 三组间食管裂孔疝复发率与内镜复发率无显著差异。
- 再次抗反流手术可能适用于不同BMI范围的患者。
核心结论
- 肥胖患者再次抗反流手术后GERD-HRQL评分改善程度与非肥胖患者相似,提示再次抗反流手术可能适用于不同BMI范围的患者。
研究设计与样本
- 回顾性队列研究,纳入2012至2023年接受机器人再次抗反流手术的84例患者,按BMI分三组:BMI<25 kg/m2(29.7%)、25≤BMI<30 kg/m2(35.7%)、BMI≥30 kg/m2(34.5%),随访12(IQR 9-14.9)个月。
主要发现
- 三组术后GERD-HRQL评分均较术前显著改善:BMI<25组术前17(IQR 12-22)降至术后7.5(IQR 1.5-15),p=0.04;25≤BMI<30组术前26(IQR 10-34)降至术后8(IQR 0-17),p<0.01;BMI≥30组术前44(IQR 26-51)降至术后5(IQR 3.5-14.5),p<0.001。
- 下食管括约肌扩张性在诱导后[3.2±2 vs 4.5±3.1 vs 3.9±2.5 mm2/mmHg,p=0.44]和胃底折叠后[1±0.6 vs 1.3±0.7 vs 1.2±0.6 mm2/mmHg,p=0.46]三组间无差异。
- 钡餐随访7(IQR 5.2-9.2)个月食管裂孔疝复发率三组间无差异[5.2 vs 15.7 vs 13.7%,p=0.32]。
- 内镜随访11.8(IQR 5.6-17.1)个月复发率三组间无差异[13.3 vs 16.6 vs 7.1%,p=0.74]。
临床怎么用
- 对于肥胖的复发性胃食管反流病患者,再次抗反流手术可考虑作为治疗选择,术后GERD-HRQL评分预期可获得与非肥胖患者相似的改善。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Obese patients represent a large proportion of patients experiencing recurrent reflux and re-operations after initial anti-reflux surgery. However, there is a limited data describing the impact of obesity on GERD recurrence following re-operative procedures. METHODS: A review of patients who underwent re-operative anti-reflux surgery (Re-ARS) between 2012 and 2023. Peri-operative characteristics and post-operative Gastroesophageal Reflux Disease-Health Related Quality of Life (GERD-HRQL) scores were compared across the three BMI categories: (BMI < 25 kg/m2, 25 ≤ BMI > 30 kg/m2, and BMI ≥ 30 kg/m2) over 12 IQR (9-14.9) months follow-up. Impedance planimetry measurements were included when it was utilized intraoperatively. RESULTS: Of 718 patients who underwent robotic ARS, 84 patients (11.6%) underwent Re-ARS, of which 29.7% had a BMI < 25 kg/m2, 35.7% were ≤ 25 BMI < 30 kg/m2, and 34.5% had a BMI ≥ 30 kg/m2. The lower esophageal sphincter distensibility decreased similarly between groups with no differences in post-induction [3.2 ± 2 vs 4.5 ± 3.1 vs 3.9 ± 2.5 mm2/mmHg, p = 0.44] or post-fundoplication values [1 ± 0.6 vs 1.3 ± 0.7 vs 1.2 ± 0.6 mm2/mmHg, p = 0.46]. There was a significant improvement in GERD-HRQL scores postoperatively compared to preoperative levels across the three BMI classes (BMI < 25 kg/m2: pre 17 IQR (12-22), post 7.5 (1.5-15), p = 0.04 vs ≤ 25 BMI < 30 kg/m2: pre 26 IQR (10-34), post 8 IQR (0-17), p < 0.01 vs BMI ≥ 30 kg/m2: pre 44 IQR (26-51), post 5 IQR (3.5-14.5), p < 0.001) during 12 IQR (9-14.9) months follow-up. The rates of hiatal hernia recurrence on barium swallow [5.2 vs 15.7 vs 13.7%, p = 0.32] during 7 IQR (5.2-9.2) months follow-up, and endoscopy [13.3 vs 16.6 vs 7.1%, p = 0.74] during 11.8 (IQR 5.6-17.1) months follow-up period were also similar between groups. CONCLUSION: GERD-HRQL scores in obese patients are expected to improve similarly compared to non-obese patients. Indicating that Re-ARS may be appropriate for patients across a range of BMIs.
引用
- Al Asadi H, Najah H, Marshall T, et al. The impact of obesity on gastroesophageal reflux disease recurrence following re-operative anti-reflux surgery. Surg Endosc. 2024. PMID: 39214878. doi:10.1007/s00464-024-11182-2
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。